JP Patent

JP7042256B2 — 薬剤関連毒性が低減した治療法および処方薬に起因する患者危害の可能性を確認する方法

Assigned to タブラ・ラサ・ヘルスケア，インコーポレーテッド · Expires 2022-03-25 · 4y expired

What this patent protects

Patent listed against Fanapt.

Drugs covered by this patent

Patent Metadata

Patent number
JP7042256B2
Jurisdiction
JP
Classification
—
Expires
2022-03-25
Drug substance claim
No
Drug product claim
No
Assignee
タブラ・ラサ・ヘルスケア，インコーポレーテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.